These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22873615)

  • 1. Can persistent Epstein-Barr virus infection induce chronic fatigue syndrome as a Pavlov reflex of the immune response?
    Agliari E; Barra A; Vidal KG; Guerra F
    J Biol Dyn; 2012; 6():740-62. PubMed ID: 22873615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.
    Ruiz-Pablos M; Paiva B; Montero-Mateo R; Garcia N; Zabaleta A
    Front Immunol; 2021; 12():656797. PubMed ID: 34867935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?
    Pender MP
    Brain; 2009 Dec; 132(Pt 12):3196-8. PubMed ID: 20008341
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.
    Xing Y; Song HM; Wei M; Liu Y; Zhang YH; Gao L
    J Immunotoxicol; 2013; 10(4):387-92. PubMed ID: 23418935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and systemic lupus erythematosus.
    James JA; Harley JB; Scofield RH
    Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and pathogenetic observations on children with chronic mononucleosis].
    Cataldo F; Ammatuna P; Bellia L; Sammartano F; Violante M; Albeggiani A
    Pediatr Med Chir; 1991; 13(5):489-94. PubMed ID: 1664943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus: exploiting the immune system.
    Thorley-Lawson DA
    Nat Rev Immunol; 2001 Oct; 1(1):75-82. PubMed ID: 11905817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic Epstein-Barr virus infection].
    Imashuku S; Teramura T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():503-7. PubMed ID: 15861702
    [No Abstract]   [Full Text] [Related]  

  • 10. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response to Epstein-Barr virus.
    Callan MF
    Microbes Infect; 2004 Aug; 6(10):937-45. PubMed ID: 15310471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study.
    Pedersen M; Asprusten TT; Godang K; Leegaard TM; Osnes LT; Skovlund E; Tjade T; Øie MG; Wyller VBB
    Brain Behav Immun; 2019 Jan; 75():94-100. PubMed ID: 30261303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
    Adhikary D; Behrends U; Moosmann A; Witter K; Bornkamm GW; Mautner J
    J Exp Med; 2006 Apr; 203(4):995-1006. PubMed ID: 16549597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.
    Katsuki T; Katsuki K; Imai J; Hinuma Y
    Jpn J Cancer Res; 1987 Jul; 78(7):639-42. PubMed ID: 3040648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic fatigue syndrome].
    Kondo K
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():490-5. PubMed ID: 16615521
    [No Abstract]   [Full Text] [Related]  

  • 16. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
    Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D
    Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ; McAulay KA; Anthony IC; Crawford DH
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.